KTKerem Teke

Kerem Teke

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kerem Teke has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nutritional-Inflammatory Sarcopenia (NIS) Score Predicts Complication Severity and Survival After Radical Cystectomy

    by Enes Malik Akdaş, Engin Telli, Hasan Yılmaz, Önder Kara, Serdar Baykal, Kerem Teke, Özdal Dillioğlugil

    Background/Objectives: Radical cystectomy (RC) results in substantial morbidity, and outcomes differ widely among comparable patients. We evaluated the Nutritional-Inflammatory Sarcopenia (NIS) score, which combines systemic inflammation, nutritional status and skeletal muscle mass, as a predictor of postoperative complications and overall survival (OS). Methods: Patients who underwent RC for pathologically confirmed urothelial bladder cancer between 2011 and 2024 were retrospectively screened. The NIS score (Kocaeli Panel) was constructed from the Prognostic Nutritional Index (PNI), the Systemic Immune-Inflammation Index (SII) and the Skeletal Muscle Index (SMI), each scored 0 or 1, giving four risk groups. Complications were graded with the Clavien–Dindo classification, and OS was analysed by Kaplan–Meier and Cox regression. Results: Of 179 patients, 152 (84.9%) were male; median age was 66 years (IQR 60–71); median follow-up was 22 months (10–50). Risk groups were low (34.6%), intermediate (30.2%), high (24.6%) and very high (10.6%); complications of any grade occurred in 103 patients and major complications (grade ≥ IIIa) in 29. Relative to low risk, major complications were more frequent in the high-risk (OR 3.80, 95% CI 1.21–11.89) and very-high-risk groups (OR 5.26, 1.39–19.91), whereas any complication did not differ (p = 0.300). OS worsened as the score increased (log-rank p < 0.001), and the score independently predicted OS in multivariable Cox analysis for all three higher-risk groups. Conclusions: The NIS score is simple to calculate from routine preoperative data. It predicted the severity rather than the occurrence of postoperative complications, independently predicted survival, and may therefore identify patients who are least able to tolerate a major complication after RC.

  • Open Access

    Molecular Biomarker Testing in Kidney Cancer: Integrating Diagnosis, Prediction, and Emerging Renal Tumor Entities

    by Busra Yaprak Bayrak, Elif Ozsagir, Nazif Alperen Yıldırım, Kerem Teke, Michael Cheng, Anna Caliò, Guido Martignoni, Mahmut Akgul, Liang Cheng

    Background: Kidney tumors comprise a biologically diverse and diagnostically challenging group of neoplasms. Many entities share overlapping morphologic features despite having distinct molecular profiles. Although histomorphology remains the cornerstone of diagnosis, molecular biomarker testing has become increasingly important for accurate classification, recognition of emerging entities, identification of hereditary cancer syndromes, and therapeutic decision-making. Focus of the Review: This narrative review provides a practical, pathology-oriented framework for molecular biomarker testing in kidney tumors. It integrates immunohistochemistry, fluorescence in situ hybridization, polymerase chain reaction-based methods, and next-generation sequencing with morphologic assessment. Particular attention is given to diagnostically relevant alterations involving VHL, TFE3, TFEB, MET, FH, ELOC, and ALK, genes encoding SDH subunits, and components of the mTOR signaling pathway, together with commonly used immunohistochemical surrogates. The prognostic and predictive roles of selected biomarkers, including their potential value in hereditary risk assessment and treatment selection, are also discussed. Practical limitations, such as limited biopsy material, intratumoral heterogeneity, and technical variability, are considered. Conclusions: Molecular biomarker testing is reshaping kidney tumor pathology by supporting an integrated diagnostic approach that complements, rather than replaces, careful morphologic evaluation. Its appropriate use can improve diagnostic accuracy, refine clinical stratification, and facilitate the recognition of emerging renal tumor entities with hereditary or therapeutic relevance. Future developments are expected to include methylation profiling, transcriptomic classifiers, liquid biopsy platforms, and artificial intelligence-assisted interpretation.

  • Open Access

    “Virgin ureter” vs. “non-virgin ureter”? A comparative analysis on complications and failure of retrograde intrarenal surgery: a multicentre case-control study from RIRSearch Group

    by Kerem Teke, Naci Burak Çınar, Önder Çınar, Murat Akgül, Cem Başataç, Muhammet Fatih Şimşekoğlu, Hakan Çakır, Oktay Özman, Mustafa Bilal Tuna, Duygu Sıddıkoğlu, et al.

    It is unclear whether ureteral virginity has an effect on retrograde intrarenal surgery (RIRS). We aimed to evaluate the impact of ureteral virginity on RIRS outcomes in a multicenter study. Data from the RIRSearch study group database were retrospectively reviewed. Patients with a history of endoluminal interventions or extrinsic ureteral surgery were categorized as having a “non-virgin ureter,” while those without such histories were classified as “virgin ureters.” Case-control matching was performed based on age, gender, uretral access sheath size, and stone characteristics. Demographic, clinical, surgical and complication data were compared after-matching. A total of 894 procedures were included, with 119 (13.3%) involving non-virgin ureters. Pre-matching, the non-virgin ureter group had higher mean age (50.6 ± 13.2 vs. 46.6 ± 13.6 years) and Charlson comorbidity index ≥ 2 (51.3% vs. 40.4%). In addition, number of stones, total-stone volume and rate of multiple stone localization were significantly higher in non-virgin ureter group. Operation time, hospital stay, surgical failure, need for auxiliary treatment, and perioperative complications were significantly higher in non-virgin ureter group ( p < 0.05). After case-matching, perioperative complications (18.7% vs. 5.3%), hospital stay (1.54 ± 1.30 vs. 1.18 ± 0.98 days), and auxiliary treatment requirements (20% vs. 8.4%) remained significantly higher in non-virgin ureter group ( p < 0.05). There was no significant difference in postoperative complication rates (17.3% vs. 19.8%) or surgical failure rates (36% vs. 26%). Non-virgin ureters were associated with higher perioperative complication rate, longer hospital stays and increased need for auxiliary treatments during RIRS. Patients with non-virgin ureters may be informed about these potential risks before surgery.